Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Jump to section
Related Articles
Cited By...
- Incidence and Risk Factors of In-Stent Restenosis for Symptomatic Intracranial Atherosclerotic Stenosis: A Systematic Review and Meta-Analysis
- Update in the treatment of intracranial atherosclerotic disease
- Symptom Differences and Pretreatment Asymptomatic Interval Affect Outcomes of Stenting for Intracranial Atherosclerotic Disease
- Temporal Correlation between Wall Shear Stress and In-Stent Stenosis after Wingspan Stent in Swine Model
- Higher Risk of Recurrent Ischemic Events in Patients With Intracranial In-Stent Restenosis
- Wingspan experience in the treatment of symptomatic intracranial atherosclerotic disease after antithrombotic failure
- Trends in Intracranial Stenting Among Medicare Beneficiaries in the United States, 2006-2010
- Standard of practice: endovascular treatment of intracranial atherosclerosis
- Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis
- Detailed Analysis of Periprocedural Strokes in Patients Undergoing Intracranial Stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS)